Search

everythinglearnresearchcommunity

for

Search:↓

Atrazine and finasteride disrupt hormone signaling and affect frog development.

There are significant gaps and inconsistencies in diagnosing and treating alopecia areata in Greece and Italy.

New nonsteroidal molecules can potentially increase dihydrotestosterone in neurons by blocking certain enzymes, without affecting prostate and seminal vesicle weight.

BST2 is a key marker for hair loss disease alopecia areata.

Accurate diagnosis of APL is crucial to avoid unnecessary treatments.

Early baldness increases prostate cancer risk, radiotherapy and surgery have similar second cancer rates, and ALA may reduce prostate cancer risk.

Arg1+ macrophages may play a role in Alopecia Areata, offering new treatment targets.

Fat tissue stem cells show promise for repairing different body tissues and are being tested in clinical trials.

Alopecia areata is the most common type of baldness treated with corticosteroids and minoxidil.

Neurosteroids help control dopamine responses in the brain.

Ovarian hyperthecosis should be considered in young women with severe male-like symptoms and can be managed with hormone treatments.

Prostate cancer cells can make their own androgens to activate the androgen receptor, and treatments like abiraterone may increase this ability, suggesting new therapies should target the entire steroid-making pathway.

Candida antigen is an effective and promising treatment for alopecia areata.

Both mouse and rat models are effective for testing alopecia areata treatments.

Dutasteride injections can help treat hair loss in men and women.

No treatments fully cure or prevent alopecia areata; some help but have side effects or need more research.

New treatments for the autoimmune hair loss condition alopecia areata may include JAK inhibitors and other immunomodulators.

Testosterone, progesterone, and levonorgestrel change enzyme levels related to fat production in hamster skin, which could affect skin oil and acne.

Sudden, unusual hair loss may indicate serious underlying health issues.

A 12-year-old boy with PAIS successfully developed male characteristics using high-dose testosterone and anastrozole.

Finasteride and dutasteride are effective in treating male hair loss but can cause sexual side effects and birth defects.

Tofacitinib was more effective than apremilast in treating hair loss in a mouse model of alopecia areata.

New drug dutasteride effectively treats hair loss, but use cautiously due to potential sexual side effects.

DM and AA may share a common cause.